MedPath

Eye movement desensitization and reprocessing therapy in early psychosis

Not Applicable
Completed
Conditions
Schizophrenia, schizotypal and delusional disorders
Mental and Behavioural Disorders
Registration Number
ISRCTN16262847
Lead Sponsor
ancashire Care NHS Foundation Trust
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33225584/ (added 16/04/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Aged at least 16 years
2. Capacity and willingness to provide informed consent
3. ICD diagnosis of schizophrenia-spectrum disorders (ICD codes F20, F22, F23, F25, F28, F29; ICD-11 codes 6A20, 6A21, 6A23, 6A24, 6A2Y,6A2Z) or LCFT EIS psychosis criteria, operationally defined using the Positive and Negative Syndrome Scale (PANSS) and/or the psychosis transition criteria of the Comprehensive Assessment of At-Risk Mental States (CAARMS)
4. In contact with mental health services, and have an assigned care-coordinator
5. Within 3 years from psychosis onset
6. Judged by the assigned care-coordinator/responsible clinician as clinically stable (no treatment change in the previous month)
7. Reporting at least 1 traumatic event on the Trauma Screening Questionnaire (TSQ), and at least subsyndromal post-traumatic symptoms in the previous week (scores > 0 on items 3_1 to 3_5 of the TSQ)
8. Meet a criterion level of positive symptoms severity, indicated by a score > 3 (symptom present) on the delusions (P1), hallucinations (P3), grandiosity (P5) or suspiciousness (P6) items of the PANSS in the previous week

Exclusion Criteria

1. Primary diagnosis of substance/alcohol dependence, intellectual disability or cognitive dysfunction, as provided by the participant care-coordinator/clinical team
2. Non-English speaking or requiring an interpreter for the intervention (the therapy and assessment battery at present can only be delivered in English)
3. Receipt of EMDR from a qualified psychological therapist in accordance with NICE guidelines for PTSD in the past 12 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath